Literature DB >> 727132

Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.

R S Meltzer, E W Robert, M McMorrow, R P Martin.   

Abstract

An unusual ventricular tachyarrhythmia developed in a 57 year old woman with recurrent ventricular tachycardia and toxic disopyramide plasma concentrations. The rhythm was similar to the patient's previous ventricular tachycardia, but the rate was slower and the QRS complex was markedly widened, mimicking the electrocardiographic changes associated with electrolyte abnormalities. Disopyramide, which has electrophysiologic properties similar to those of quinidine, probably caused the arrhythmia and should be added to the list of drugs associated with atypical ventricular tachycardia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727132     DOI: 10.1016/0002-9149(78)90694-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Severe hypoglycemia associated with disopyramide.

Authors:  J M Nappi; S Dhanani; J R Lovejoy; C VanderArk
Journal:  West J Med       Date:  1983-01

Review 2.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 3.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

4.  Satalol-induced torsade de pointes.

Authors:  A Kontopoulos; A Filindris; F Manoudis; P Metaxas
Journal:  Postgrad Med J       Date:  1981-05       Impact factor: 2.401

5.  Torsade de pointes.

Authors:  S K Agarwal
Journal:  J Natl Med Assoc       Date:  1981-10       Impact factor: 1.798

6.  The effect of prenylamine on the QT interval of the resting electrocardiogram in patients with angina pectoris.

Authors:  D Oakley; K Jennings; R Puritz; D Krikler; D Chamberlain
Journal:  Postgrad Med J       Date:  1980-11       Impact factor: 2.401

7.  Successful management of serious disopyramide poisoning.

Authors:  D W Holt; M Helliwell; B O'Keeffe; A M Hayler; C B Marshall; G Cook
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

Review 8.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 9.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 10.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.